ArticleScientific reports2025
Transformer attention fusion for fine grained medical image classification.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Twelve Fused Models by Fusing Four Types of Transformer-Based Tuners on Three Base UNet Architectures for Carotid Wall Segmentation and Plaque Burden/Intima-Media Thickness Measurements in Ultrasound Scans: A Scientific Validation Study.Diagnostics (Basel, Switzerland) · 2026Article
- A Verifiable Framework for Brain Tumor Classification: Combining Vision Transformers, Class-Weighted Learning, and SMT-Based Formal Decision Traces.Diagnostics (Basel, Switzerland) · 2026Article
- Integrating domain-specific convolutional features with Swin Transformers for transparent cervical cancer diagnostics.Frontiers in oncology · 2026Article
- Enhancing fundus image analysis for diabetic retinopathy using CheXNet with CBAM and Grad-CAM visualization.Frontiers in medicine · 2026Article
- From brain scans to classifiers: A systematic review of ML-based autism diagnostic frameworks.Digital healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fine-grained visual classification is fundamental for medical image applications because it detects minor lesions. Diabetic retinopathy (DR) is a preventable cause of blindness, which requires exact and timely diagnosis to prevent vision damage. The challenges automated DR classification systems face include irregular lesions, uneven distributions between image classes, and inconsistent image quality that reduces diagnostic accuracy during early detection stages. Our solution to these problems includes MSCAS-Net (Multi-Scale Cross and Self-Attention Network), which uses the Swin Transformer as the backbone. It extracts features at three different resolutions (12 × 12, 24 × 24, 48 × 48), allowing it to detect subtle local features and global elements. This model uses self-attention mechanics to improve spatial connections between single scales and cross-attention to automatically match feature patterns across multiple scales, thereby developing a comprehensive information structure. The model becomes better at detecting significant lesions because of its dual mechanism, which focuses on both attention points. MSCAS-Net displays the best performance on APTOS and DDR and IDRID benchmarks by reaching accuracy levels of 93.8%, 89.80% and 86.70%, respectively. Through its algorithm, the model solves problems with imbalanced datasets and inconsistent image quality without needing data augmentation because it learns stable features. MSCAS-Net demonstrates a breakthrough in automated DR diagnostics since it combines high diagnostic precision with interpretable abilities to become an efficient AI-powered clinical decision support system. The presented research demonstrates how fine-grained visual classification methods benefit detecting and treating DR during its early stages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.